Home > Balance Sheet > BIOCON

BIOCON
Total Non-Current Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹16,493 Cr₹15,120 Cr₹20,742 Cr₹6,803 Cr₹5,497 Cr

What is the latest Total Non-Current Liabilities ratio of BIOCON ?

The latest Total Non-Current Liabilities ratio of BIOCON is ₹16,493 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹16,493 Cr
Mar2024₹15,120 Cr
Mar2023₹20,742 Cr
Mar2022₹6,803 Cr
Mar2021₹5,497 Cr

How is Total Non-Current Liabilities of BIOCON Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹16,493 Cr
9.08
Mar2024 ₹15,120 Cr
-27.11
Mar2023 ₹20,742 Cr
204.91
Mar2022 ₹6,803 Cr
23.76
Mar2021 ₹5,497 Cr -

Compare Total Non-Current Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹48,045.1 Cr 4.7% -8.9% 6.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

4.7%

-8.9%

6.9%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses